Lazard, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Lazard Ltd on March 22, 2010, covering events occurring on March 16, 2010. The filing details a secondary equity offering by selling shareholders and a concurrent change in the company's Board of Directors.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The primary financial data relates to a specific capital transaction:
- Shares Offered: 7,869,311 shares of Class A common stock.
- Offering Price: $35.90 per share.
- Underwriter: Goldman, Sachs & Co.
- Proceeds: Proceeds from the sale were received by the Selling Shareholders, not the Company.
Material Changes
The filing reports two material changes:
- Secondary Offering: Selling shareholders divested 7,869,311 shares of Class A common stock. This transaction was approved by the Board of Directors on March 12, 2010.
- Board Composition: Ellis Jones will cease serving as a member of the Board of Directors on or before the 2010 Annual General Meeting of Shareholders.
Guidance, Outlook, and Governance Changes
The filing contains no financial guidance, outlook, or management commentary regarding future performance. However, it discloses a significant governance agreement:
- Termination of Nomination Right: The Company, Lazard Group LLC, and the Trustees of the Cranberry Dune 1998 Long-term Trust entered into a Letter Agreement. Upon completion of the stock offering, the Trust agreed to terminate Lazard's obligation to nominate one person designated by the Trust to the Board of Directors.
- Director Departure: As part of this agreement, Ellis Jones will not stand for reelection at the 2010 Annual General Meeting.
Investor Verification Checklist
- Verify the identity of the "Selling Shareholders" in the Prospectus Supplement to understand the source of the shares sold.
- Confirm the exact date of Ellis Jones' departure from the Board relative to the 2010 Annual General Meeting.
- Review the attached Letter Agreement (Exhibit 10.1) for any additional covenants or conditions related to the termination of the Trust's nomination rights.
- Check subsequent filings for the final count of shares sold and any changes in beneficial ownership.